我要投票 艾德生物AmoyDx在基因检测行业中的票数:813
· 外 推 电 报 ·
2026-01-08 15:46:08 星期四

【艾德生物AmoyDx是哪个国家的品牌?】

艾德生物AmoyDx是什么牌子?「艾德生物AmoyDx」是 厦门艾德生物医药科技股份有限公司 旗下著名品牌。该品牌发源于福建省厦门市,由创始人LI-MOU ZHENG在2008-02-21期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力艾德生物AmoyDx品牌出海!将品牌入驻外推网,定制艾德生物AmoyDx品牌推广信息,可以显著提高艾德生物AmoyDx产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

厦门艾德生物医药科技股份有限公司由“千人计划”国家特聘专家郑立谋教授于2008年回国创办,集肿瘤医疗诊断产品的研发、生产、销售、服务为一体,同时具备三类体外诊断产品生产/经营资质及独立临床医学检验资质。

公司自有厂区50亩,具备前沿的研究中心和国际标准的GMP厂房,获得国家药监局(CFDA)和欧盟ISO13485资质认证,下设厦门艾德医学检验所,专业从事第三方分子检测服务。公司拥有自主知识产权的ADx-ARMS®、Super-ARMS®两大技术平台,打破了跨国企业的技术垄断,在短短几年内成长为细分领域重要企业。基于专利技术,针对目前肿瘤医疗重要的EGFR、KRAS、BRAF、EML4-ALK、PIK3CA、ROS1、NRAS、Her-2等基因,公司陆续研发的13种基因检测产品。

基于技术与产品优势,公司构建了完备的营销体系,产品已进入全球50多个国家和地区的数百家大中型医院、科研院所销售,是多家跨国药企在肿瘤分子诊断技术领域的合作伙伴,赢得了良好的市场声誉和广泛的客户认可,成为享誉国际的民族品牌。


英文翻译:Xiamen Eide Biomedical Technology Co., Ltd. was founded in 2008 by Professor Zheng Limu, a national special expert of "thousand talents plan". It integrates the research and development, production, sales and service of tumor medical diagnosis products, and has the qualification of production / operation of three kinds of in vitro diagnosis products and independent clinical medical examination. The company has a plant area of 50 mu, with cutting-edge research center and GMP plant of international standards. It has obtained the qualification certification of CFDA and EU ISO13485. It has Xiamen Eide medical laboratory, which specializes in the third-party molecular testing services. The company has two technology platforms of ADX arms ® and super arms ® with independent intellectual property rights, breaking the technology monopoly of multinational enterprises and growing into an important enterprise in the subdivision field in a few years. Based on patented technology, the company has successively developed 13 gene detection products for EGFR, KRAS, BRAF, EML4-ALK, PIK3CA, ros1, NRAS, HER-2 and other genes that are important for tumor medical treatment. Based on the advantages of technology and products, the company has established a complete marketing system. The products have been sold in hundreds of large and medium-sized hospitals and scientific research institutes in more than more than 50 countries and regions around the world. It is a partner of many multinational pharmaceutical enterprises in the field of tumor molecular diagnosis technology, and has won a good market reputation and wide customer recognition. It has become an international famous national brand.

本文链接: https://www.waitui.com/brand/b23fe6416.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

蔚来今年将进军澳大利亚和新西兰市场,蔚来将于3月进入泰国市场

据报道,蔚来今年将进军澳大利亚和新西兰市场,蔚来将于3月进入泰国市场。(新浪财经)

2小时前

现货白银向下跌破76美元/盎司

36氪获悉,现货白银向下跌破76美元/盎司,日内下跌2.79%。

2小时前

霸王茶姬回应赴港上市传闻:暂无计划

对于拟赴港二次上市的传闻,霸王茶姬方面回应称,暂无计划。(澎湃)

2小时前

瑞银:外资对中国市场关注度明显回升

瑞银证券董事长胡知鸷透露,将于下周在上海举办的第26届瑞银大中华区研讨会,注册参会客户总数创历史新高,达到3600人,其中投资者约2300人,总体增长11%。值得关注的是,来自美国、欧洲、中东、非洲地区的参会者增长达32%,亚洲以外的全球资金对中国市场的关注度明显回升。外资正从此前相对被动的等待或进进出出的流动状态,转向更主动、长期、有标的可选择的参与交易。(财联社)

2小时前

神经科技品牌LumiMind发布LumiSleep

在CES 2026上,神经科技品牌LumiMind发布首款消费级实时调控脑电睡眠仪LumiSleep。据了解,该产品基于毫秒级脑电监测与闭环神经调控技术,通过实时解析脑电并生成个性化声学引导,帮助大脑自然进入睡眠状态,推动睡眠科技从“被动监测”迈向“主动引导”。其核心技术源自岩思类脑人工智能研究院在脑电解码与脑机接口领域的长期基础研究成果。该产品计划于2026年上半年正式上市,未来会拓展至情绪调节、专注力提升及长期脑健康管理等方向。

2小时前

本页详细列出关于艾德生物AmoyDx的品牌信息,含品牌所属公司介绍,艾德生物AmoyDx所处行业的品牌地位及优势。
咨询